Back to top

Valneva jumps as Lyme disease vaccine developed with Pfizer undergoes EU review

Valneva jumps as Lyme disease vaccine developed with Pfizer undergoes EU review

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Pfizer Inc. (PFE)

Valneva SE Sponsored ADR (VALN)